Gartner, Inc. (IT)

Revance Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,198	1,933	1,319	698	756.49	712.58
Trading Asset Securities	1.17	3.1	5.96	6.35	-	-
Cash & Short-Term Investments	2,199	1,936	1,325	704.35	756.49	712.58
Cash Growth	76.94%	46.14%	88.11%	-6.89%	6.16%	153.74%
Receivables	1,319	1,727	1,630	1,578	1,385	1,256
Prepaid Expenses	119.08	119.09	91.65	91.05	93.68	94.77
Restricted Cash	-	-	0.6	-	4.11	-
Other Current Assets	337.01	413.91	380.66	412.74	380.57	259.76
Total Current Assets	3,974	4,197	3,428	2,786	2,620	2,323
Property, Plant & Equipment	492.46	500.39	629.53	701.17	821.82	984.05
Goodwill	2,938	2,930	2,937	2,930	2,951	2,946
Other Intangible Assets	375.94	409.69	501.96	584.71	714.42	807
Long-Term Deferred Tax Assets	-	262.76	144.71	138.32	140	103.56
Other Long-Term Assets	547.73	235.1	194.57	159.21	168.69	152.76
Total Assets	8,328	8,535	7,836	7,300	7,416	7,316
Accounts Payable	812.11	55.79	63.14	83.23	49.28	38.59
Accrued Expenses	-	1,011	893.79	855.87	955.18	763.9
Current Portion of Long-Term Debt	0.36	-	9.6	7.8	27.73	55.4
Current Portion of Leases	89.63	100.31	98.49	99.72	89.75	84
Current Income Taxes Payable	-	38.69	72.18	76.38	18.72	29.55
Current Unearned Revenue	2,691	2,763	2,641	2,444	2,238	1,975
Other Current Liabilities	0.18	-	-	30.84	0.09	1.51
Total Current Liabilities	3,594	3,969	3,778	3,598	3,379	2,947
Long-Term Debt	2,462	2,460	2,449	2,454	2,489	2,033
Long-Term Leases	311.15	339.78	513.41	597.27	697.77	780.17
Long-Term Unearned Revenue	23.12	27.39	33.49	39.12	48.18	26.75
Long-Term Deferred Tax Liabilities	-	48.74	86.55	139.53	181.79	173.23
Other Long-Term Liabilities	405.5	146.94	138.39	120.44	110.88	137.12
Total Liabilities	6,795	7,176	7,155	7,072	7,045	6,226
Common Stock	0.08	0.08	0.08	0.08	0.08	0.08
Additional Paid-In Capital	2,603	2,497	2,320	2,180	2,075	1,969
Retained Earnings	6,445	5,993	4,739	3,857	3,049	2,255
Treasury Stock	-7,469	-7,043	-6,303	-5,707	-4,672	-3,035
Comprehensive Income & Other	-46.62	-88.33	-76.33	-101.61	-81.43	-99.23
Shareholders' Equity	1,533	1,359	680.63	227.8	371.06	1,090
Total Liabilities & Equity	8,328	8,535	7,836	7,300	7,416	7,316
Total Debt	2,863	2,900	3,070	3,158	3,304	2,952
Net Cash (Debt)	-664.07	-963.76	-1,745	-2,454	-2,548	-2,240
Net Cash Per Share	-8.53	-12.30	-21.90	-30.27	-29.56	-24.88
Filing Date Shares Outstanding	75.74	76.82	77.97	79.06	82.29	88.72
Total Common Shares Outstanding	76.8	77.38	78.34	79.17	82.4	88.84
Working Capital	380.2	227.52	-349.83	-811.49	-758.7	-624.44
Book Value Per Share	19.95	17.56	8.69	2.88	4.50	12.27
Tangible Book Value	-1,781	-1,981	-2,759	-3,287	-3,295	-2,662
Tangible Book Value Per Share	-23.19	-25.60	-35.21	-41.52	-39.99	-29.96
Machinery	-	458.39	403.69	348.4	401.44	392.6
Leasehold Improvements	-	190.45	213.21	220.51	253.45	283.77
Order Backlog	-	191.5	163	-	-	-

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q